Proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stage

Bladder cancer (BC) is a worldwide common disease with a high mortality rate. Recognizing the dynamic changes in plasma that proteases and their inhibitors undergo might be valuable in understanding the carcinogenesis of invasive bladder cancer and in identifying BC patients with poor prognosis. Thi...

Full description

Bibliographic Details
Main Authors: Dmytryk Viktor, Luhovska Tetiana, Yakovlev Pavel, Savchuk Olexiy, Halenova Tetiana, Raksha Nataliia, Ostapchenko Ludmila
Format: Article
Language:English
Published: Sciendo 2020-06-01
Series:Current Issues in Pharmacy and Medical Sciences
Subjects:
Online Access:https://doi.org/10.2478/cipms-2020-0013
id doaj-07aab31f29534765a4edf602e9e63ac9
record_format Article
spelling doaj-07aab31f29534765a4edf602e9e63ac92021-09-06T19:22:04ZengSciendoCurrent Issues in Pharmacy and Medical Sciences2084-980X2300-66762020-06-01332677110.2478/cipms-2020-0013cipms-2020-0013Proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stageDmytryk Viktor0Luhovska Tetiana1Yakovlev Pavel2Savchuk Olexiy3Halenova Tetiana4Raksha Nataliia5Ostapchenko Ludmila6ESC “The Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, UkraineESC “The Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, UkraineDepartment of Urology, O. Bogomolets National Medical University, Kyiv, UkraineESC “The Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, UkraineESC “The Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, UkraineESC “The Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, UkraineESC “The Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, UkraineBladder cancer (BC) is a worldwide common disease with a high mortality rate. Recognizing the dynamic changes in plasma that proteases and their inhibitors undergo might be valuable in understanding the carcinogenesis of invasive bladder cancer and in identifying BC patients with poor prognosis. This study aims to determine the activity of the proteolytic enzyme system and their inhibitors in patients with BC. In this paper, the total proteolytic activity, the activity of matrix metalloproteases (MMPs) and serine proteases was analyzed by the method of caseinolytic activity. For detection of activity of some inhibitors of proteolysis, we used the unified method for determining the activity of alpha-1-antitrypsin (α1A) and alpha-2-Macroglobulin (α2M) in human plasma. The level of medium-mass molecules (MMM) was assessed spectrophotometrically by applying the Nikolaichik method.https://doi.org/10.2478/cipms-2020-0013bladder cancerserine proteasesmmpsα1aα2mmedium mass molecules
collection DOAJ
language English
format Article
sources DOAJ
author Dmytryk Viktor
Luhovska Tetiana
Yakovlev Pavel
Savchuk Olexiy
Halenova Tetiana
Raksha Nataliia
Ostapchenko Ludmila
spellingShingle Dmytryk Viktor
Luhovska Tetiana
Yakovlev Pavel
Savchuk Olexiy
Halenova Tetiana
Raksha Nataliia
Ostapchenko Ludmila
Proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stage
Current Issues in Pharmacy and Medical Sciences
bladder cancer
serine proteases
mmps
α1a
α2m
medium mass molecules
author_facet Dmytryk Viktor
Luhovska Tetiana
Yakovlev Pavel
Savchuk Olexiy
Halenova Tetiana
Raksha Nataliia
Ostapchenko Ludmila
author_sort Dmytryk Viktor
title Proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stage
title_short Proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stage
title_full Proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stage
title_fullStr Proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stage
title_full_unstemmed Proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stage
title_sort proteolytic parameter changes in the plasma of patients with bladder cancer – depending on tumor stage
publisher Sciendo
series Current Issues in Pharmacy and Medical Sciences
issn 2084-980X
2300-6676
publishDate 2020-06-01
description Bladder cancer (BC) is a worldwide common disease with a high mortality rate. Recognizing the dynamic changes in plasma that proteases and their inhibitors undergo might be valuable in understanding the carcinogenesis of invasive bladder cancer and in identifying BC patients with poor prognosis. This study aims to determine the activity of the proteolytic enzyme system and their inhibitors in patients with BC. In this paper, the total proteolytic activity, the activity of matrix metalloproteases (MMPs) and serine proteases was analyzed by the method of caseinolytic activity. For detection of activity of some inhibitors of proteolysis, we used the unified method for determining the activity of alpha-1-antitrypsin (α1A) and alpha-2-Macroglobulin (α2M) in human plasma. The level of medium-mass molecules (MMM) was assessed spectrophotometrically by applying the Nikolaichik method.
topic bladder cancer
serine proteases
mmps
α1a
α2m
medium mass molecules
url https://doi.org/10.2478/cipms-2020-0013
work_keys_str_mv AT dmytrykviktor proteolyticparameterchangesintheplasmaofpatientswithbladdercancerdependingontumorstage
AT luhovskatetiana proteolyticparameterchangesintheplasmaofpatientswithbladdercancerdependingontumorstage
AT yakovlevpavel proteolyticparameterchangesintheplasmaofpatientswithbladdercancerdependingontumorstage
AT savchukolexiy proteolyticparameterchangesintheplasmaofpatientswithbladdercancerdependingontumorstage
AT halenovatetiana proteolyticparameterchangesintheplasmaofpatientswithbladdercancerdependingontumorstage
AT rakshanataliia proteolyticparameterchangesintheplasmaofpatientswithbladdercancerdependingontumorstage
AT ostapchenkoludmila proteolyticparameterchangesintheplasmaofpatientswithbladdercancerdependingontumorstage
_version_ 1717772758272704512